Protai Company
Protai empowers drug discovery with proteomics and artificial intelligence to unlock new layers of biological insights and to combat complex diseases. Protai's platform has made a leap in solving how drug candidates are created and validated, facilitating quicker and more advanced drug discovery.
Industry:
Early Drug Development
Headquarters:
Tel Aviv, Tel Aviv, Israel
Founded Date:
2021-01-01
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
2
Total Funding:
8000000
Last Funding Date:
2022-01-05
Last Funding Type:
Seed
Register and Claim Ownership